- Home
- PMTS vs CRMD Comparison
PMTS vs CRMD Comparison
Compare PMTS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMTS | CRMD |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.1M | 943.9M |
| IPO Year | 2015 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PMTS | CRMD |
|---|---|---|
| Price | $14.94 | $12.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $32.00 | $17.43 |
| AVG Volume (30 Days) | 53.9K | ★ 2.6M |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.20 | ★ 2.25 |
| Revenue | ★ $515,576,000.00 | $214,303,672.00 |
| Revenue This Year | $13.70 | $627.89 |
| Revenue Next Year | $8.51 | $40.95 |
| P/E Ratio | $12.69 | ★ $5.56 |
| Revenue Growth | 12.48 | ★ 1647.67 |
| 52 Week Low | $11.64 | $5.60 |
| 52 Week High | $34.25 | $17.43 |
Technical Indicators
Market Signals| Indicator | PMTS | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.08 | 66.86 |
| Support Level | $14.78 | $11.78 |
| Resistance Level | $18.23 | $12.51 |
| Average True Range (ATR) | 0.84 | 0.52 |
| MACD | -0.19 | 0.13 |
| Stochastic Oscillator | 8.55 | 96.68 |
Price Performance
Historical ComparisonAbout PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.